Insiders · Profile

Anderman Jonathan

Gen Counsel & Corporate Sec at Compass Therapeutics. Filing since 7 Apr 2025. CIK 0002032625

Company

Date

Role

Action

Amount

Of holding

7 Apr 2025

Gen Counsel & Corporate Sec

Bought

20,000

$30.80K

×20

1 decision on file.